Skip to main content

Table 1 Participant’s characteristics in the groups under study

From: Effect of valerian on cognitive disorders and electroencephalography in hemodialysis patients: a randomized, cross over, double-blind clinical trial

Index

Group

Aa

B

Number

Percent

Number

Percent

Sex

Female

10

52.6

9

45

Mal

9

47.4

11

55

Body Mass Index

> 18.5

1

5.3

3

15

18.5–24.9

12

63.2

12

60

25–29.9

6

31.6

5

25

Education level

illiterate

6

31.6

7

35

Elementary

9

47.4

6

30

Diploma or higher

4

21.1

7

35

Income

Low

4

21.1

6

30

Average

14

73.7

14

70

Good

1

5.2

–

–

Dialysis causes

DM

7

36.8

5

25

HTN

4

21.1

4

20

DM,HTN

4

21.1

8

40

Other

4

21.1

3

15

HD

+

5

26.3

5

25.0

–

14

73.7

15

75.0

RLL

+

13

68.4

9

45/0

–

6

31.6

11

55.0

Number of cups of tea

0

–

–

2

10

1

5

26.3

5

25

2

13

68.4

10

50

≥3

1

5.3

3

15

  1. aThe group A took valerian capsules in the first therapeutic period of one month and placebo in the second therapeutic period of one month, and vice versa in group B